The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 December;58(4)

EDITORIAL  PET IN NEURODEGENERATIVE DISORDERS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 December;58(4):329-31

Functional imaging in neurodegenerative disorders: past, present and future

Pagani M., Sonni I., Capriotti G.

PDF

REVIEWS  PET IN NEURODEGENERATIVE DISORDERSFree access

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 December;58(4):332-43

Guidance for reading FDG PET scans in dementia patients

Herholz K.

Abstract PDF

REVIEWS  PET IN NEURODEGENERATIVE DISORDERS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 December;58(4):344-54

Positron emission tomography neuroimaging in amyotrophic lateral sclerosis: what is new?

Quartuccio N., Van Weehaeghe D., Cistaro A., Jonsson C., Van Laere K., Pagani M.

Abstract PDF

REVIEWS  PET IN NEURODEGENERATIVE DISORDERS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 December;58(4):355-65

18F-FDOPA PET for the diagnosis of parkinsonian syndromes

Darcourt J., Schiazza A., Sapin N., Dufour M., Ouvrier M. J., Benisvy D., Fontana X., Koulibaly P. M.

Abstract PDF

REVIEWS  PET IN NEURODEGENERATIVE DISORDERS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 December;58(4):366-75

Functional imaging in pre-motor Parkinson’s disease

Arnaldi D., Morbelli S., Picco A., Ferrara M., Buschiazzo A., Famà F., De Carli F., Nobili F.

Abstract PDF

REVIEWS  PET IN NEURODEGENERATIVE DISORDERS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 December;58(4):376-86

Radioligand imaging of α4β2* nicotinic acetylcholine receptors in Alzheimer’s disease and Parkinson’s disease

Meyer P. M., Tiepolt S., Barthel H., Hesse S., Sabri O.

Abstract PDF

REVIEWS  PET IN NEURODEGENERATIVE DISORDERS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 December;58(4):387-97

Brain imaging for oxidative stress and mitochondrial dysfunction in neurodegenerative diseases

Okazawa H., Ikawa M., Tsujikawa T., Kiyono Y., Yoneda M.

Abstract PDF

REVIEWS  PET IN NEURODEGENERATIVE DISORDERS

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 December;58(4):398-412

Voyage au bout de la nuit: Aβ and tau imaging in dementias

Zwan M. D., Okamura N., Fodero-Tavoletti M. T., Furumoto S., Masters C. L., Rowe C. C., Villemagne V. L.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 December;58(4):413-23

Metabolic impact of partial volume correction of [18F]FDG PET-CT oncological studies on the assessment of tumor response to treatment

Stefano A., Gallivanone F., Messa C., Gilardi M. C., Castiglioni I.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 December;58(4):424-39

Partial volume corrected 18F-FDG PET mean standardized uptake value correlates with prognostic factors in breast cancer

Gallivanone F., Canevari C., Sassi I., Zuber V., Marassi A., Gianolli L., Picchio M., Messa C., Gilardi M. C., Castiglioni I.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 December;58(4):440-50

Monitoring of atherosclerosis evolution by detection of inflammatory states of aortae in a rabbit model using 18F-FDG -PET/CT

Zhao Q. M., Zhao X., Feng T. T., Zhang M. D., Zhuang X. C., Zhao X. C., Zhang X. X., Su G.

Abstract PDF